PORTLAND — Idexx Laboratories President and CEO Jonathan Ayers touted the company’s latest initiatives in diagnosing pet health on Friday, the morning after its stock closed at a record high.

In some ways, Idexx has put diagnostics for pet health ahead of the human health field, said Ayers, speaking at Eggs & Issues, a monthly event put on by the Portland Community Chamber at Holiday Inn By the Bay.

Using Idexx’s products, a veterinarian can analyze a pet’s blood sample within the time of an appointment, which allows pet owners to discuss the results with the doctor before leaving. Another product compares the results of that blood test to others taken over the animal’s lifetime, which can indicate trends that act as warning signs before there’s a detectable problem.

Like a company’s annual revenue, Ayers said, the significance of blood test results for a pet — or a human — is in comparing it to past results. Under Ayers’ leadership, Idexx’s revenue has grown from $386 million to $1.2 billion, said Michael Bourque, president of the chamber’s board.

Taking measurements, whether they are of financial or physical health, inform us how to manage situations, Ayers said.

“Can you imagine if you managed your body like you manage your business?” he said.